SLNO icon

Soleno Therapeutics

15 hedge funds and large institutions have $8.5M invested in Soleno Therapeutics in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 4 closing their positions.

Holders
15
Holders Change
+2
Holders Change %
+15.38%
% of All Funds
0.37%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
4
Reduced
3
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
VC
1
Vivo Capital
California
$7.64M 14,695,264
Deutsche Bank
2
Deutsche Bank
Germany
$311K 601,423 +25,670 +4%
PAI
3
Palo Alto Investors
California
$220K 84,748 -338,990 -80%
Vanguard Group
4
Vanguard Group
Pennsylvania
$105K 202,427 +144,413 +249%
6CM
5
683 Capital Management
New York
$78K 150,000 +150,000 New
BlackRock
6
BlackRock
New York
$41K 77,995 +399 +0.5%
VF
7
Virtu Financial
New York
$28K 52,942 +52,942 New
TSS
8
Two Sigma Securities
New York
$23K 44,230 +44,230 New
Renaissance Technologies
9
Renaissance Technologies
New York
$14K 26,570 +26,570 New
Citadel Advisors
10
Citadel Advisors
Florida
$14K 27,368 +27,368 New
UBS Group
11
UBS Group
Switzerland
$9K 16,718 +12,375 +285%
Northern Trust
12
Northern Trust
Illinois
$7K 14,376
Goldman Sachs
13
Goldman Sachs
New York
$5K 10,170 -18,776 -65%
Morgan Stanley
14
Morgan Stanley
New York
$1K 1,084 -316 -23%
SM
15
Sabby Management
Florida
-248,067 Closed
BG
16
Bollard Group
Massachusetts
-192,217 Closed
Bank of America
17
Bank of America
North Carolina
-6,851 Closed
Creative Planning
18
Creative Planning
Kansas
-1,300 Closed
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$0 7 +7 New